Relmada Therapeutics (RLMD): Narxning foydaga va o‘sish sur’atiga nisbati
Relmada Therapeutics (RLMD) REL-1017 dori vositasidan foydalangan holda NMDA retseptorlarini modulyatsiya qilish orqali depressiyani davolashning innovatsion usullarini ishlab chiqadi. PEG koeffitsiyenti tarixi baholash dinamikasini namoyish etadi, bunda 0.00 ko'rsatkichi ushbu metrikaning miqdorini belgilaydi. Operatsion model ishlab chiqarish va klinik sinovlarning to'liq autsorsingiga asoslangan. Biroq, biznes spekulyativ esometadon patentlariga tayanadi va muvaffaqiyat kelgusidagi sinovlar natijalariga bog'liq.
Relmada Therapeutics (RLMD) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati relmada.com|RLMD - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Relmada|RLMD - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Relmada Therapeutics|Oraliq qoplash koeffitsiyenti relmada.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
RLMD - Sof foyda|Kutilayotgan sof foyda Relmada Therapeutics|RLMD - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Relmada Corp|RLMD - PEG multiplikatori|EV/EBITDA multiplikatori Relmada|RLMD - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Relmada Therapeutics|RLMD - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi relmada.com|RLMD - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Relmada Therapeutics
Kompaniyaning jamlanma tahliliyoti:Relmada Therapeutics Inc, RLMD
Relmada Therapeutics (RLMD) uchun fundamental xatarlar aksiya narxini foyda dinamikasi bilan solishtirishni talab qiladi. REL-1017 dorisining tijoratlashtirilishini kutayotgan biotexnologiya startapi uchun kengayish sur'atlarini baholash juda muhimdir. GURU.Markets platformasidagi joriy PEG qiymati P/E koeffitsiyentining sof foyda yillik o'sishiga nisbatini aks ettiradi. Birga solishtirganda birdan past qiymat aktivning o'z potentsialiga nisbatan qadrsizlanganligidan dalolat beradi. Grafik tahlili bozor boshqaruv samaradorligini yetarli darajada baholayotganini aniqlash imkonini beradi.
Relmada Therapeutics kimlar bilan raqobatlashadi
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|Regencell Corp - Narxning foydaga va o‘sish sur’atiga nisbati|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|acadia-pharm.com (ACAD) - Narx-foyda va o‘sish multiplikatori|XENE: PEG multiplikatori|Viking Therapeutics Inc (VKTX) - PEG multiplikatori|SUPN (Supernus Pharma) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CPRX (Catalyst Corp)|PEG multiplikatori DNLI|PEG multiplikatori harmonybiosciences.com (HRMY)|Biohaven - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|TRVI: Narx-foyda va o‘sish multiplikatori|Praxis Corp - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|AVXL: PEG multiplikatori|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PRTA (Prothena Corporation plc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alector Therapeutics ALEC|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER (omeros.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NGNE (Neurogene Inc.)|PEG multiplikatori acimmune.com ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tevogen Bio Inc. (TVGN)|Narx-foyda va o‘sish multiplikatori ACOG|PEG multiplikatori cogrx.com|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAVA|PEG multiplikatori ASRT (Assertio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - PEG multiplikatori|Ovid Therapeutics Inc. (OVID) - Narx-foyda va o‘sish multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|CRVO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|CLNN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|Narxning foydaga va o‘sish sur’atiga nisbati JUNS (jupiterneurosciences.com)|Narxning foydaga va o‘sish sur’atiga nisbati Annovis Bio ANVS|GRCE - Narx-foyda va o‘sish multiplikatori|Firefly Neuroscience Inc - PEG multiplikatori|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RVPH|MTVA (MetaVia Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NeurAxis Inc. NRXS|Narx-foyda va o‘sish multiplikatori HSDT (Helius Medical)|PEG multiplikatori passagebio.com (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NERV|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Addex Therapeutics Ltd.|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PTIX (Protagenic Therapeutics Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|Narxning foydaga va o‘sish sur’atiga nisbati ATXI (Avenue Therapeutics Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Narx-foyda va o‘sish multiplikatori|Chromocell Therapeutics - PEG multiplikatori|ELYM - PEG multiplikatori|ITCI: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|MRNS (Marinus) - PEG multiplikatori|PEG multiplikatori NKGen Biotech Corp|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TRVN (Trevena Inc.)|Vigil Neuro - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE: PEG multiplikatori
